6.45
0.04 (0.62%)
| Penutupan Terdahulu | 6.41 |
| Buka | 6.48 |
| Jumlah Dagangan | 581,766 |
| Purata Dagangan (3B) | 514,433 |
| Modal Pasaran | 666,843,264 |
| Harga / Buku (P/B) | 5.99 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.90 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.41% |
| Nisbah Semasa (MRQ) | 11.06 |
| Aliran Tunai Operasi (OCF TTM) | -78.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -47.17 M |
| Pulangan Atas Aset (ROA TTM) | -32.92% |
| Pulangan Atas Ekuiti (ROE TTM) | -56.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Aura Biosciences, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.10 |
|
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.98% |
| % Dimiliki oleh Institusi | 76.19% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Matrix Capital Management Company, Lp | 31 Mar 2026 | 6,922,870 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BITETTI TERESA MARIE | 6.21 | - | 15,000 | 93,150 |
| JOHNSON DAVID MICHAEL | 6.21 | - | 15,000 | 93,150 |
| MATTESSICH ANTONY C. | 6.21 | - | 15,000 | 93,150 |
| SRIVASTAVA SAPNA | 6.21 | - | 15,000 | 93,150 |
| Jumlah Keseluruhan Kuantiti Bersih | 60,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 372,600 | |||
| Purata Pembelian Keseluruhan ($) | 6.21 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MATTESSICH ANTONY C. | Pengarah | 11 Jun 2026 | Diperolehi (+) | 15,000 | 6.21 | 93,150 |
| JOHNSON DAVID MICHAEL | Pengarah | 11 Jun 2026 | Diperolehi (+) | 15,000 | 6.21 | 93,150 |
| SRIVASTAVA SAPNA | Pengarah | 11 Jun 2026 | Diperolehi (+) | 15,000 | 6.21 | 93,150 |
| BITETTI TERESA MARIE | Pengarah | 11 Jun 2026 | Diperolehi (+) | 15,000 | 6.21 | 93,150 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |